ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerabilityKiran Kumar Reddi(University of Alabama at Birmingham), Romi Gupta(University of Alabama at Birmingham)Cell Death and DiseaseJune 26, 202410.1038/s41419-024-06831-2Cited by 6SaveCiteExport RISWatch citationsRelated PapersDisruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis|Oncogenesis|2021|29